Is XLV a buy or sell right now?

Innellis AI committee rates Health Care Select Sector SPDR Insufficient Data with a composite score of 64/100.

Do analysts agree on XLV?

3 AI analysts evaluated Health Care Select Sector SPDR, with 100 percent agreement on the overall direction.

XLV · NASDAQ · ETF

Health Care Select Sector SPDR (XLV) ETF Analysis

Financial Services Updated August 23, 2026

$174.62

52W $133.73 – $176.60

AI Score

64/100

Market Cap

$44.85B

P/E Ratio

—

Beta

0.51

Is XLV Bullish or Bearish?

Mixed. Innellis AI committee rates Health Care Select Sector SPDR (XLV) Insufficient Data with a composite score of 64/100 , based on 3 analysts with 100% agreement. Last updated August 23, 2026.

What Would Change This View

No threshold can be published for XLV. The committee has not produced a scored recommendation, so there is no line for it to cross. Innellis does not infer one.

Executive Summary

The primary driver is news sentiment is positive (+0.27 across 30 articles, 14d). The main limiting factor is sector concentration is already high (hhi 3069.37). The committee is constructive but not yet at full conviction.

Bull & Bear Case

Bull Case

Price structure making higher highs and higher lows — Technical
MACD histogram positive -- bullish momentum — Technical
Trend and market structure agree -- coherent bullish picture — Technical
Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
News sentiment is positive (+0.27 across 30 articles, 14d) — News

Bear Case

RSI at 71 is in overbought territory — Technical
Weekly RSI at 83 -- overbought on the larger timeframe too — Technical

Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.

Price History (6M)

AI Investment Committee

Committee Consensus As of August 23, 2026

Overall Committee Score

64/100

Agreement

100%

Analysts

Conviction

Low Data

Sector Rank

Top 29%

of 212 Financial Services peers

Technical Analyst bullish

61 / 100 · High confidence

Price action is constructive -- trend and momentum agree

+ Price structure making higher highs and higher lows

− RSI at 71 is in overbought territory

Macro Analyst bullish

65 / 100 · Low confidence

Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor

News Analyst bullish

66 / 100 · Low confidence

News flow and recent filings/analyst actions are net positive

+ News sentiment is positive (+0.27 across 30 articles, 14d)

Portfolio Manager neutral

45 / 100 · High confidence

Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position

+ Portfolio position concentration is currently healthy

− Sector concentration is already high (HHI 3069.37)

Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 64.1 to 64.1.

Comparing 2026-08-22 to 2026-08-23 (1 day apart).

Technical Analysis

RSI (14)

70.7

Overbought

MACD Histogram

0.617

Bullish Momentum

Trend Direction

Uptrend

Weekly: Uptrend

Market Structure

Hh Hl

Bollinger %B

0.98

Inside Bands

Price vs Moving Averages

EMA 9

$170.67 Above

EMA 21

$167.44 Above

EMA 50

$162.49 Above

EMA 200

$153.76 Above

Fundamental Analysis

Valuation

P/E Ratio —

P/B Ratio —

PEG Ratio —

Dividend Yield —

52W High $176.60

52W Low $133.73

Quality & Growth

ROE —

ROA —

Gross Margin —

Operating Margin —

Revenue Growth YoY —

Debt / Equity —

AI Fundamental Assessment

[reduced confidence: limited earnings history] Earnings-history trend unavailable; growth based on TTM year-over-year only.

Get the Full XLV Analysis

Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A

Open in Terminal →